Form D — Immunomic Therapeutics, Inc.
0001543256-25-000002 · filed 2025-06-02
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $16,000,000
- Total sold
- $6,500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Immunomic Therapeutics, Inc.
- CIK
- 1543256
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- ATTN: Erin Duffy, 15010 BROSCHART RD.
ROCKVILLE, MD 20850 - Phone
- 301-968-3509
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Dong-Gun Kim · Executive OfficerROCKVILLE, MD Find on LinkedIn ↗
-
Robert Ahlgren · DirectorROCKVILLE, MD Find on LinkedIn ↗
-
Steve Park · DirectorROCKVILLE, MD Find on LinkedIn ↗
-
Ki-Hong Ahn · DirectorROCKVILLE, MD Find on LinkedIn ↗
-
Matthew Chang · DirectorROCKVILLE, MD Find on LinkedIn ↗
-
James Wishart · DirectorROCKVILLE, MD Find on LinkedIn ↗
-
Yang Gon Jin · DirectorROCKVILLE, MD Find on LinkedIn ↗
View original on SEC EDGAR.